The potential of artificial intelligence to improve patient safety: a scoping review.
The potential of artificial intelligence to improve patient safety: a scoping review.
复制标题
DOI：
10.1038/s41746-021-00423-6
复制
发表时间：
2021-03-19
影响因子：
15.2
通讯作者：
Rhee K
中科院分区：
文献类型：
--
作者：
Bates DW;Levine D;Syrowatka A;Kuznetsova M;Craig KJT;Rui A;Jackson GP;Rhee K
人工智能（AI）是一种可用于提高护理安全性的宝贵工具。医疗保健中的主要不良事件包括：医疗保健相关感染、药物不良事件、静脉血栓栓塞、手术并发症、压疮、跌倒、代偿失代偿和诊断错误。本综述的目的是总结相关文献，并评估人工智能在这八个危害领域改善患者安全的潜力。使用结构化搜索在MEDLINE查询相关文章。范围审查确定了描述人工智能在每个危害领域中用于预测、预防或早期检测不良事件的研究。人工智能文献对每个领域进行了叙述性的综合，并在发生率、成本和可预防性的背景下考虑了研究结果，以预测人工智能提高安全性的可能性。392项研究纳入了范围评价。文献提供了许多例子，说明人工智能如何使用各种技术在八个危害领域中的每一个领域中应用。最常见的新数据是通过不同类型的传感技术收集的：生命体征监测、可穿戴设备、压力传感器和计算机视觉。利用人工智能和新数据源来减少所有领域的伤害频率有很大的机会。我们预计人工智能将在当前战略无效的领域产生最大的影响，对新颖的非结构化数据进行整合和复杂分析是做出准确预测所必需的；这特别适用于药物不良事件、代偿失调和诊断错误。
Artificial intelligence (AI) represents a valuable tool that could be used to improve the safety of care. Major adverse events in healthcare include: healthcare-associated infections, adverse drug events, venous thromboembolism, surgical complications, pressure ulcers, falls, decompensation, and diagnostic errors. The objective of this scoping review was to summarize the relevant literature and evaluate the potential of AI to improve patient safety in these eight harm domains. A structured search was used to query MEDLINE for relevant articles. The scoping review identified studies that described the application of AI for prediction, prevention, or early detection of adverse events in each of the harm domains. The AI literature was narratively synthesized for each domain, and findings were considered in the context of incidence, cost, and preventability to make projections about the likelihood of AI improving safety. Three-hundred and ninety-two studies were included in the scoping review. The literature provided numerous examples of how AI has been applied within each of the eight harm domains using various techniques. The most common novel data were collected using different types of sensing technologies: vital sign monitoring, wearables, pressure sensors, and computer vision. There are significant opportunities to leverage AI and novel data sources to reduce the frequency of harm across all domains. We expect AI to have the greatest impact in areas where current strategies are not effective, and integration and complex analysis of novel, unstructured data are necessary to make accurate predictions; this applies specifically to adverse drug events, decompensation, and diagnostic errors.
登录
查看更多内容
影响因子：
6.3
作者：
Florence CS;Bergen G;Atherly A;Burns E;Stevens J;Drake C
通讯作者：
Drake C
影响因子：
4.9
作者：
Beeler, Cole;Dbeibo, Lana;Azar, Jose
通讯作者：
Azar, Jose
影响因子：
6.9
作者：
Geilleit, R.;Hen, Z. Q.;de Korne, D. F.
通讯作者：
de Korne, D. F.
影响因子：
6
作者：
Bates, David W.;Heitmueller, Axel;Saria, Suchi
通讯作者：
Saria, Suchi
影响因子：
9.7
作者：
Bates, David W.;Singh, Hardeep
通讯作者：
Singh, Hardeep